triamcinolone acetonide has been researched along with Disease Models, Animal in 126 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (7.14) | 18.7374 |
| 1990's | 17 (13.49) | 18.2507 |
| 2000's | 33 (26.19) | 29.6817 |
| 2010's | 59 (46.83) | 24.3611 |
| 2020's | 8 (6.35) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chao, W; Chen, H; Gao, H; Huang, C; Qi, X; Wang, H | 1 |
| Chen, AD; Chen, RF; Huang, YT; Kuo, YR; Lai, CS; Li, YT; Lin, SD | 1 |
| Cheng, T; Cheng, Y; Li, J; Qu, Y; Zhang, X | 1 |
| Benoit, JP; Formica, ML; Luna, JD; Palma, SD; Tártara, LI; Ullio Gamboa, GV | 1 |
| Cho, HJ; Jeon, SY; Jeon, YJ; Joo, YH; Jung, MH; Kim, JH; Kim, SW; Park, JJ; Suh, YS | 1 |
| Hasegawa, N; Shibuya, K | 1 |
| Alves, JC; Carreira, LM; Jorge, P; Lavrador, C; Santos, A | 1 |
| Hua, Z; Wei, P | 1 |
| Hong, JT; Jang, M; Jung, H; Kang, BM; Kim, KH; Kwon, O; Ohn, J; Yang, H | 1 |
| Cho, JG; Choi, B; Choi, S; Kim, H; Lee, SJ; Lim, H; Min, H; Oh, JH; Park, JS | 1 |
| Erdiakov, AK; Gavrilova, SA; Tikhonovich, MV | 1 |
| Chang, CJ; Chang, SY; Chen, HC; Chuang, SS; Hsiao, YC; Yang, JY; Yang, SY; Yen, CI | 1 |
| Makino, K; Shimamura, Y; Takeuchi, I; Terada, H | 1 |
| Arnhold, E; Ávila, MP; McCulley, TJ; Paula, AC; Pereira, LS; Salustiano, LX | 1 |
| Hampton, T | 1 |
| Ahmadi, N; Arnoldner, C; Gabor, F; Gausterer, JC; Honeder, C; Nieratschker, M; Saidov, N; Schöpper, H; Zhu, C | 1 |
| Canning, P; Klaassen, I; Schlingemann, RO; van der Wijk, AE; van Heijningen, RP; van Noorden, CJF; Vogels, IMC | 1 |
| Bi, H; Guo, D; Guo, J; Li, Q; Sun, Y; Wei, H; Wu, S; Yin, X; Zhao, Q | 1 |
| Etienne, I; Feyen, JHM; Lefevere, E; Moons, L; Sergeys, J; Stalmans, I; Van Bergen, T; Van Hove, I | 1 |
| Creemers, L; Eijkelkamp, N; Emans, P; Mihov, G; Rudnik-Jansen, I; Schrijver, K; Tellegen, A; Thies, J; Tryfonidou, M; Versteeg, S; Woike, N | 1 |
| Ambrosius, B; Bachir, H; Gold, R; Grüter, T; Motte, J; Pedreiturria, X; Pitarokoili, K; Sgodzai, M; Yoon, MS | 1 |
| Creemers, LB; de Gendt, E; de Visser, HM; Egas, A; Emans, PJ; Kik, MJL; Meij, BP; Mihov, G; Pouran, B; Rudnik-Jansen, I; Schrijver, K; Tellegen, AR; Thies, J; Thomas, RE; Tryfonidou, MA; van Maarseveen, E; Weinans, H; Woike, N | 1 |
| Li, Y; Mu, G; Zhang, F; Zhang, L | 1 |
| Abarca, EM; Gilger, BC; Patel, S; Salmon, JH | 1 |
| Chae, SW; Jin, HJ; Jin, SM; Kim, DH; Lee, HS; Lee, SH; Lee, SU; Sohn, JH | 1 |
| Adibkia, K; Atyabi, F; De Geest, BG; Dinarvand, R; Ghahremani, MH; Hashemi, H; Khoshayand, MR; Mohsenzadeh, N; Sabzevari, A | 1 |
| Dai, W; He, B; Li, W; Liu, Y; Zhang, Q | 1 |
| Li, Z; Liang, XS; Wen, YL; Yang, B | 1 |
| Holwegner, C; Marx, DB; Reinhardt, AL; Reinhardt, RA; Schmid, MJ | 1 |
| Ayyıldız, O; Durukan, AH; Gunal, A; Ozgurtas, T | 1 |
| Baek, S; Chang, M; Lee, Y | 1 |
| Chen, S; Huang, W; Jonas, JB; Wang, J; Zhang, X | 1 |
| Arnoldner, C; Engleder, E; Gabor, F; Gstoettner, W; Hirtler, L; Honeder, C; Kaider, A; Landegger, LD; Plasenzotti, R; Plenk, H | 1 |
| Hara, H; Kizaka-Kondoh, S; Kuchimaru, T; Masuda, T; Nagasawa, H; Nakamura, S; Shimazawa, M; Takata, S; Tsuruma, K | 1 |
| Cheng, L; Gu, B; Li, X; Liu, J; Ma, Q; Shen, M | 1 |
| Bastiaansen-Jenniskens, Y; de Jong, M; Groen, H; Korthagen, N; Müller, C; Siebelt, M; Waarsing, JH; Wei, W; Weinans, H | 1 |
| Chang, CH; Chang, SW; Huang, TL; Lin, KH; Tsai, RK; Wen, YT | 1 |
| Fraile, JM; Garcia-Martin, E; Mayoral, JA; Otín-Mallada, S; Pablo, LE; Polo-Llorens, V; Prieto, E; Vispe, E | 1 |
| Candia, O; Danias, J; Fridman, G; Gerometta, R; Rybkin, I | 1 |
| Chuang, SS; Hsiao, YC; Yang, JY; Yang, SY | 1 |
| Bakar, B; Budak Yildiran, FA; Dincel, GC; Sari, E | 1 |
| Criswell, MH; Hu, WZ; Li, R; Margaron, P; Steffens, TJ | 1 |
| Chen, SD; McAllister, IL; Vijayasekaran, S; Yu, DY | 1 |
| Ahmadi, F; Eghtedari, M; Hosseini, H; Mehryar, M; Nowroozizadeh, S | 1 |
| Acland, GM; Aguirre, GD; Beltran, WA; Gu, D; Li, Z; Pearce-Kelling, S | 1 |
| Aşik, G; Ayçiçek, A; Cetinkaya, Z; Kenar, F; Kiraz, N; Kiyici, H | 1 |
| Borrás, T; Candia, OA; Gerometta, R; Spiga, MG | 1 |
| Chung, SK; Kang, S | 1 |
| Kim, SJ; Toma, HS | 1 |
| Barnett, JM; Kim, SJ; Penn, JS; Toma, HS | 1 |
| Cho, GJ; Choi, WS; Chung, IY; Kim, YH; Park, JM; Seo, SW; Yoo, JM | 1 |
| Choi, WS; Chung, IY; Kim, YH; Park, YJ; Yoo, JM | 1 |
| Cringle, SJ; McAllister, IL; McMenamin, PG; Mendis, KR; Morgan, WH; Vijayasekaran, S; Yu, DY | 1 |
| Chen, X; Kong, YS; Li, WR; Wang, W | 1 |
| Atkins, S; Boissonade, FM; Loescher, AR; Metcalfe, AD; Morgan, CR; Ngeow, WC; Robinson, PP | 1 |
| Bringmann, A; Drechsler, F; Hollborn, M; Köferl, P; Kohen, L; Rehak, M; Wiedemann, P | 1 |
| Honda, M; Hori, Y; Kojima, F; Nakamura, T; Nishizawa, Y; Shigeno, K; Shionoya, Y; Yamamoto, K | 1 |
| Ahrens, K; Bräutigam, M; Fölster-Holst, R; Gläser, R; Harder, J; Jensen, JM; Meingassner, J; Proksch, E; Scherer, A; Schwarz, T; Stütz, A | 1 |
| Bonini-Filho, MA; Crispim, PT; Cunha, AS; Damico, FM; Haddad, A; Jorge, R; Maia-Filho, A; Messias, A; Oliveira, RC; Ribeiro, JA; Saliba, JB; Scott, IU; Siqueira, RC | 1 |
| Gao, Y; Li, S; Qiu, Y; Zhang, S | 1 |
| Andrade, SP; Ayres, E; Da Silva, GR; Da Silva-Cunha Junior, A; Lima, LD; Moura, SA; Oréfice, RL; Pinto, FC | 1 |
| Amarante, J; Brown, S; Correia-Sá, I; D S Cordeiro, MN; Gonçalves-Rodrigues, A; Marques, M; Rodrigues-Pereira, P | 1 |
| May, CA | 1 |
| Ambati, BK; Archer, B; Cho, YK; Uehara, H; Young, JR | 1 |
| Gao, YH; Li, S; Qiu, YQ; Zhang, SH | 1 |
| Ambati, B; Archer, B; Cho, YK; Uehara, H; Young, JR; Zhang, X | 1 |
| Choi, WS; Chung, IY; Kim, SJ; Kim, YH; Yoo, JM | 1 |
| Balaskas, K; Eperon, S; Guex-Crosier, Y; Gurny, R; Rodriguez-Aller, M | 1 |
| Danias, J; Deutsch, ER; Kumar, S; Shah, S; Tang, HM | 1 |
| Berthelot, JM; Le Goff, B; Maugars, Y | 1 |
| Bingöl, AO; Elhensheri, M; Iannitti, T; Palmieri, B | 1 |
| Blanco, JC; Ottolini, MG; Porter, DD; Prince, GA | 1 |
| Holz, FG; Miller, DW | 1 |
| Ciulla, TA; Cox, TA; Criswell, MH; Csaky, KG; Danis, RP; Fronheiser, M; Robinson, MR; Yuan, P | 1 |
| Blume, G; Cevc, G | 1 |
| Blanco, J; Curtis, S; Ottolini, M; Peterson, L; Porter, D; Prince, G | 1 |
| Eichelberger, MC; Ottolini, MG; Prince, GA | 1 |
| Bucher, RS; Hall, E; Johnson, MW; Reed, DM; Richards, JE; Zacks, DN | 1 |
| Hammes, HP; Jonas, JB; Sauder, G; Schubert, U; Spandau, UH | 1 |
| Kato, A; Kimura, H; Kunou, N; Nozaki, M; Ogura, Y; Okabe, J; Okabe, K | 1 |
| Bringmann, A; Francke, M; Gamsalijew, R; Makarov, F; Osborne, NN; Pannicke, T; Reichenbach, A; Uckermann, O; Uhlmann, S; Ulbricht, E; Wiedemann, P | 1 |
| Kim, JH; Lee, MC; Wee, GR | 1 |
| Geisen, P; Hartnett, ME; Martiniuk, DJ; McColm, JR; Peterson, LJ; Saito, Y | 1 |
| Aydin, E; Kazi, AA; Kivilcim, M; Peyman, GA; Riazi-Esfahani, M; Sanders, DR | 1 |
| Boldt, C; Carter, KD; Folk, J; Nerad, JA; Song, A | 1 |
| Behar-Cohen, F; BenEzra, D; Doat, M; Dot, C; Jeanny, JC; Jonet, L; May, F | 1 |
| Akkoyun, I; Akova, YA; Haberal, N; Kahraman, B; Oto, S; Yilmaz, G | 1 |
| Miyake, T; Mizuno, S; Morita, H; Nishiwaki, A; Ogura, Y | 1 |
| Aydin, B; Erdurmus, M; Hepsen, IF; Karadag, R; Turkmen, C; Yagci, R; Yilmaz, B | 1 |
| Romundstad, L; Stubhaug, A | 1 |
| Li, H; Strong, JA; Xie, W; Zhang, JM | 1 |
| Chen, H; Levin, L; Ritter, AL; Teixeira, FB; Trope, M | 1 |
| Hauge, EM; Herlin, T; Kristensen, KD; Küseler, A; Nyengaard, JR; Pedersen, TK; Stoustrup, P | 1 |
| Hammes, HP; Jonas, JB; Spandau, UH; Vom Hagen, F | 1 |
| Bhisitkul, RB; Dunaief, JL; Hahn, P; He, X; Lee, OT; Pereira, Dde S; Porco, TC; Winn, BJ; Wong, J | 1 |
| Aydin, E; Esfahani, MR; Kazi, AA; Kivilcim, M; Peyman, GA; Sanders, DR | 1 |
| Matsubara, A; Mizuno, D; Ogura, Y | 1 |
| Iwai, N; Kimura, O; Kubota, Y; Miyagi, H; Ono, S; Sasaki, Y; Tsuda, T | 1 |
| van den Berg, WB; van der Kraan, PM; Verschure, PJ; Vitters, EL | 1 |
| Ando, N; Berkowitz, BA; de Juan, E; Sen, HA; Wilson, CA | 1 |
| Antoszyk, AN; Gottlieb, JL; Hatchell, DL; Machemer, R | 1 |
| Cai, YS; Heimann, K; Hui, YN; Kirchhof, B; Liang, HC | 1 |
| Frantzen, E; Goebeler, M; Goerdt, S; Sorg, C | 1 |
| Porter, DD; Prince, GA | 1 |
| Bingaman, DP; Danis, RP; Ladd, B; Yang, Y | 1 |
| Frisbie, DD; Nixon, AJ | 1 |
| Bolton, L; Ladin, DA; Morris, DE; Mustoe, TA; Roth, SI; Wu, L; Zhao, LL | 1 |
| Head, WS; O'Day, DM; Robinson, RD; Shetlar, D; Wang, MX; Yang, R | 1 |
| Ciulla, TA; Criswell, MH; Danis, RP; Hill, TE | 1 |
| Goldlust, MB; Harrity, TW; Rich, LC | 1 |
| Bayard, S; Sanen, FJ; Van Scott, E | 1 |
| Dorey, FJ; Kabo, JM; Meals, RA; Namba, RS | 1 |
| Chandler, DB; Forbes, VS; Hida, T; Machemer, R; Rozakis, G | 1 |
| Chen, EP; Hatchell, DL; Saloupis, PT; Samsa, GP; Steinhorst, UH | 1 |
| Head, WS; O'Day, DM; Ray, WA; Robinson, RD; Williams, TE | 1 |
| Hu, CC; Jaskoll, T; Melnick, M | 1 |
| Martel-Pelletier, J; Pelletier, JP | 1 |
| Hendrickx, AG; Tarara, RP | 1 |
| Chandler, DB; de Juan, E; Machemer, R; Rozakis, G | 1 |
| Rosen, M; Swai, EA | 1 |
| Chandler, DB; Hida, T; Machemer, R; Proia, AD; Sheta, S | 1 |
| Burde, RM; Sugar, A; Sugar, J | 1 |
| Maestrone, G; Mitrovic, M; Sadek, S | 1 |
| De Ruggieri, P; Frova, C; Maistrello, I; Rigamonti, G | 1 |
| Longauer, J; Weirich, FG | 1 |
3 review(s) available for triamcinolone acetonide and Disease Models, Animal
| Article | Year |
|---|---|
Model systems for the study of steroid-induced IOP elevation.
Topics: Animals; Cell Culture Techniques; Dexamethasone; Disease Models, Animal; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Organ Culture Techniques; Trabecular Meshwork; Triamcinolone Acetonide | 2017 |
Side effects of corticosteroid injections: what's new?
Topics: Adrenal Cortex Hormones; Animals; Calcinosis; Dexamethasone; Disease Models, Animal; Humans; Injections; Nervous System Diseases; Risk Factors; Sepsis; Triamcinolone Acetonide | 2013 |
[Pharmacological therapy for age-related macular degeneration. Current developments and perspectives].
Topics: Adrenal Cortex Hormones; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Choroidal Neovascularization; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease Models, Animal; Endothelial Growth Factors; Eye Proteins; Fluorescein Angiography; Fundus Oculi; Haplorhini; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Matrix Metalloproteinase Inhibitors; Nerve Growth Factors; Neuroprotective Agents; Photochemotherapy; Placebos; Proteins; Rats; Serpins; Time Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Visual Acuity | 2003 |
1 trial(s) available for triamcinolone acetonide and Disease Models, Animal
| Article | Year |
|---|---|
Dose titration of steroidal and non-steroidal topical anti-inflammatory agents.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Desonide; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical; Edema; Eye Diseases; Female; Fibroblasts; Glucocorticoids; Humans; Inflammation; Mitosis; Psoriasis; Rabbits; Triamcinolone Acetonide; Vagina; Vasoconstrictor Agents | 1975 |
122 other study(ies) available for triamcinolone acetonide and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Monolith/Hydrogel composites as triamcinolone acetonide carriers for curing corneal neovascularization in mice by inhibiting the fibrinolytic system.
Topics: Animals; Cell Line; Cornea; Corneal Neovascularization; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Drug Stability; Humans; Hydrogels; Male; Mice; Mice, Inbred BALB C; Triamcinolone Acetonide | 2022 |
Triamcinolone Acetonide Suppresses Keloid Formation Through Enhancing Apoptosis in a Nude Mouse Model.
Topics: Animals; Apoptosis; Disease Models, Animal; In Situ Nick-End Labeling; Injections, Intralesional; Keloid; Mice; Mice, Nude; Triamcinolone Acetonide | 2019 |
Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
Topics: Administration, Ophthalmic; Animals; Biological Availability; Blood-Retinal Barrier; Chitosan; Coated Materials, Biocompatible; Disease Models, Animal; Drug Delivery Systems; Female; Fluorescent Dyes; Glucocorticoids; Intraocular Pressure; Intravitreal Injections; Liposomes; Ophthalmic Solutions; Papilledema; Rats; Rats, Inbred BN; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2019 |
Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Drug Stability; Epithelium, Corneal; Humans; Lipids; Male; Nanocapsules; Particle Size; Rabbits; Solubility; Surface-Active Agents; Temperature; Triamcinolone Acetonide; Uveitis | 2020 |
Therapeutic Effects of Intranasal Tofacitinib on Chronic Rhinosinusitis with Nasal Polyps in Mice.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Chronic Disease; Cytokines; Disease Models, Animal; Eosinophilia; Eosinophils; Humans; Janus Kinases; Male; Mice; Nasal Mucosa; Nasal Polyps; Piperidines; Pyrimidines; Rhinitis; Signal Transduction; Sinusitis; STAT Transcription Factors; Triamcinolone Acetonide | 2021 |
Development of an Animal Model of Onychomycosis in Guinea Pigs.
Topics: Animals; Arthrodermataceae; Disease Models, Animal; Guinea Pigs; Humans; Immunosuppression Therapy; Injections, Intramuscular; Male; Nails; Onychomycosis; Triamcinolone Acetonide | 2020 |
The intra-articular administration of triamcinolone hexacetonide in the treatment of osteoarthritis. Its effects in a naturally occurring canine osteoarthritis model.
Topics: Age Distribution; Animals; Body Weight; Disease Models, Animal; Dogs; Female; Injections, Intra-Articular; Male; Osteoarthritis, Hip; Sex Distribution; Tomography, X-Ray Computed; Triamcinolone Acetonide | 2021 |
Botulinum toxin type a intralesional monotherapy for treating human hypertrophic scar in a dose-dependent manner: In an animal model.
Topics: Animals; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Disease Models, Animal; Humans; Injections, Intralesional; Triamcinolone Acetonide | 2021 |
Dissolving Candlelit Microneedle for Chronic Inflammatory Skin Diseases.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Chronic Disease; Disease Models, Animal; Drug Delivery Systems; Female; Inflammation; Mice; Mice, Inbred C57BL; Needles; Skin; Skin Diseases; Triamcinolone Acetonide | 2021 |
Polyamidoamine dendrimer-conjugated triamcinolone acetonide attenuates nerve injury-induced spinal cord microglia activation and mechanical allodynia.
Topics: Animals; Anti-Inflammatory Agents; Calcium-Binding Proteins; Cells, Cultured; Cytokines; Dendrimers; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Hyperalgesia; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; NADPH Oxidase 2; NADPH Oxidases; Peripheral Nerve Injuries; Spinal Cord; Triamcinolone Acetonide | 2017 |
Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Concanavalin A; Disease Models, Animal; Intravitreal Injections; Piroxicam; Rats; Rats, Wistar; Retina; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative; Vitreous Body | 2018 |
Comparison of Steroid and Botulinum Toxin Type A Monotherapy with Combination Therapy for Treating Human Hypertrophic Scars in an Animal Model.
Topics: Animals; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Disease Models, Animal; Drug Therapy, Combination; Glucocorticoids; Humans; Mice; Mice, Nude; Triamcinolone Acetonide | 2017 |
A Mouse Model for Oral Mucositis Induced by Cancer Chemotherapy.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Disease Models, Animal; Fluorouracil; Male; Mice, Inbred ICR; Stomatitis; Triamcinolone Acetonide | 2018 |
Intravitreal Triamcinolone Acetonide Injection in a Rodent Model of Anterior Ischemic Optic Neuropathy.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glucocorticoids; Intravitreal Injections; Optic Nerve; Optic Neuropathy, Ischemic; Rats; Rats, Wistar; Retinal Ganglion Cells; Treatment Outcome; Triamcinolone Acetonide; Visual Fields | 2018 |
Enzyme-Responsive Hydrogels May Help Treat Arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Disease Models, Animal; Drug Delivery Systems; Drug Therapy, Combination; Humans; Hydrogels; Immunosuppressive Agents; Mice; Triamcinolone Acetonide | 2018 |
Evaluation of Sustained-Release Steroid Hydrogels in a Guinea Pig Model for Noise-Induced Hearing Loss.
Topics: Animals; Auditory Threshold; Cochlea; Delayed-Action Preparations; Dexamethasone; Disease Models, Animal; Female; Glucocorticoids; Guinea Pigs; Hearing; Hearing Loss, Noise-Induced; Hydrogels; Male; Triamcinolone Acetonide | 2018 |
Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Cattle; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Glucocorticoids; Macular Edema; Retinal Vessels; Tight Junctions; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2019 |
Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Female; Gene Expression Regulation; Humans; Interleukin-10; Interleukin-7; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Rats; Triamcinolone Acetonide; Uveitis | 2019 |
Longitudinal In Vivo Characterization of the Streptozotocin-Induced Diabetic Mouse Model: Focus on Early Inner Retinal Responses.
Topics: Angiogenesis Inhibitors; Animals; Contrast Sensitivity; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Electroretinography; Follow-Up Studies; Glucocorticoids; Immunohistochemistry; Leukostasis; Male; Mice; Mice, Inbred C57BL; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retina; Streptozocin; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2019 |
Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model.
Topics: Acrylic Resins; Animals; Biocompatible Materials; Disease Models, Animal; Female; Inflammation; Injections, Intra-Articular; Knee Joint; Microspheres; Osteoarthritis; Pain; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Synovial Membrane; Triamcinolone Acetonide | 2019 |
Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Cell Culture Techniques; Disease Models, Animal; Freund's Adjuvant; Gene Expression Regulation; Injections, Spinal; Lymph Nodes; Male; Neural Conduction; Neuritis, Autoimmune, Experimental; Oxidative Stress; Rats; Rats, Inbred Lew; Schwann Cells; SOXE Transcription Factors; Thy-1 Antigens; Triamcinolone Acetonide | 2019 |
Local controlled release of corticosteroids extends surgically induced joint instability by inhibiting tissue healing.
Topics: Animals; Biocompatible Materials; Disease Models, Animal; Female; Injections, Intra-Articular; Joint Instability; Microspheres; Osteoarthritis; Rats; Rats, Sprague-Dawley; Triamcinolone Acetonide; Wound Healing | 2019 |
Synergistic protective effects of escin and low‑dose glucocorticoids on blood‑retinal barrier breakdown in a rat model of retinal ischemia.
Topics: Animals; Blood-Retinal Barrier; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Escin; Glucocorticoids; Ischemia; Male; Occludin; Permeability; Protective Agents; Rats; Rats, Sprague-Dawley; Retinal Vessels; Triamcinolone Acetonide | 2013 |
Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles.
Topics: Acute Disease; Animals; Aqueous Humor; Cell Count; Choroid; Disease Models, Animal; Electroretinography; Extracellular Space; Eye Proteins; Female; Glucocorticoids; Intraocular Pressure; Intravitreal Injections; Leukocytes; Male; Needles; Sus scrofa; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis, Posterior; Vitreous Body | 2013 |
Morphological and histological changes of rabbit vocal fold after steroid injection.
Topics: Animals; Atrophy; Collagen; Disease Models, Animal; Glucocorticoids; Injections; Laryngeal Diseases; Laryngoscopy; Prospective Studies; Rabbits; Severity of Illness Index; Triamcinolone Acetonide; Vocal Cords; Wound Healing | 2013 |
Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
Topics: Absorbable Implants; Animals; Aqueous Humor; Disease Models, Animal; Drug Delivery Systems; Female; Glucocorticoids; Nanoparticles; Polymers; Rabbits; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2013 |
Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Carriers; Glycolates; Intravitreal Injections; Lactic Acid; Microspheres; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Triamcinolone Acetonide; Uveitis | 2014 |
[Effects of sacral canal injection on nerve root local inflammatory factors in rat model with lumbar disc herniation].
Topics: Animals; Dinoprostone; Disease Models, Animal; Injections; Interleukin-1; Interleukin-6; Intervertebral Disc Displacement; Lumbar Vertebrae; Male; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Spinal Nerve Roots; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha | 2014 |
Impact of local steroid or statin treatment of experimental temporomandibular joint arthritis on bone growth in young rats.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Juvenile; Bone Density; Cephalometry; Disease Models, Animal; Drug Carriers; Drug Combinations; Ethanol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imaging, Three-Dimensional; Injections, Intra-Articular; Male; Mandible; Mandibular Condyle; Organ Size; Rats; Rats, Sprague-Dawley; Simvastatin; Temporomandibular Joint Disorders; Triamcinolone Acetonide; X-Ray Microtomography | 2015 |
A comparison of intravitreal bevacizumab and steroid activity in an experimental uveitis model.
Topics: Angiogenesis Inhibitors; Animals; Aqueous Humor; Bevacizumab; Disease Models, Animal; Glucocorticoids; Intravitreal Injections; Male; Rabbits; Serum Albumin, Bovine; Triamcinolone Acetonide; Uveitis; Vascular Endothelial Growth Factor A | 2015 |
The functional and histopathologic change in the levator palpebrae superioris and Müller muscle after subconjunctival injection of triamcinolone acetonide.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Disease Models, Animal; Eyelid Diseases; Eyelids; Muscle Contraction; Myosin Light Chains; Oculomotor Muscles; Rabbits; Triamcinolone Acetonide | 2015 |
Intravitreal triamcinolone acetonide, retinal microglia and retinal ganglion cell apoptosis in the optic nerve crush model.
Topics: Animals; Apoptosis; Biomarkers; Blotting, Western; Cell Count; Cell Survival; Disease Models, Animal; Female; Fluorescent Antibody Technique, Indirect; Glucocorticoids; Intercellular Adhesion Molecule-1; Intravitreal Injections; Microglia; Microscopy, Confocal; Nerve Crush; Nitric Oxide Synthase Type II; Optic Nerve Diseases; Rats, Sprague-Dawley; Retinal Ganglion Cells; Retinal Neurons; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha | 2016 |
Effects of intraoperatively applied glucocorticoid hydrogels on residual hearing and foreign body reaction in a guinea pig model of cochlear implantation.
Topics: Action Potentials; Animals; Cochlea; Cochlear Implantation; Cochlear Implants; Dexamethasone; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Female; Foreign-Body Reaction; Glucocorticoids; Guinea Pigs; Hearing; Hydrogels; Intraoperative Care; Male; Neutrophil Infiltration; Triamcinolone Acetonide | 2015 |
The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe.
Topics: Animals; Choroidal Neovascularization; Disease Models, Animal; Electroretinography; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lasers; Male; Mice; Mice, Inbred C57BL; Molecular Probes; Oxygen; Protein Structure, Tertiary; Proteolysis; Rhodamines; Triamcinolone Acetonide | 2015 |
Real-Time Monitoring of Suprachoroidal Space (SCS) Following SCS Injection Using Ultra-High Resolution Optical Coherence Tomography in Guinea Pig Eyes.
Topics: Animals; Choroid; Disease Models, Animal; Extracellular Space; Guinea Pigs; Indocyanine Green; Injections, Intraocular; Intraocular Pressure; Tomography, Optical Coherence; Triamcinolone Acetonide | 2015 |
Triamcinolone acetonide activates an anti-inflammatory and folate receptor-positive macrophage that prevents osteophytosis in vivo.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Macrophage Activation; Macrophages; Male; Osteoarthritis; Osteophyte; Rats; Rats, Wistar; Triamcinolone Acetonide | 2015 |
Efficacy of Intravitreal Injections of Triamcinolone Acetonide in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy.
Topics: Animals; Apoptosis; Disease Models, Animal; Dose-Response Relationship, Drug; Evoked Potentials, Visual; Glucocorticoids; Intravitreal Injections; Male; Optic Nerve; Optic Neuropathy, Ischemic; Rats; Rats, Wistar; Treatment Outcome; Triamcinolone Acetonide | 2016 |
Determination of Three Corticosteroids in the Biologic Matrix of Vitreous Humor by HPLC-tandem Mass Spectrometry: Method Development and Validation.
Topics: Animals; Chromatography, High Pressure Liquid; Dexamethasone; Disease Models, Animal; Female; Glucocorticoids; Intravitreal Injections; Methylprednisolone; Rabbits; Retinal Diseases; Tandem Mass Spectrometry; Triamcinolone Acetonide; Vitreous Body | 2017 |
A Comparison of Gene Expression of Decorin and MMP13 in Hypertrophic Scars Treated With Calcium Channel Blocker, Steroid, and Interferon: A Human-Scar-Carrying Animal Model Study.
Topics: Adolescent; Adult; Animals; Burns; Calcium Channel Blockers; Child; Child, Preschool; Cicatrix; Cicatrix, Hypertrophic; Decorin; Dermatologic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression; Glucocorticoids; Humans; Injections, Intradermal; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Keloid; Matrix Metalloproteinase 13; Mice; Mice, Inbred BALB C; Mice, Nude; Triamcinolone Acetonide; Verapamil; Young Adult | 2017 |
Effects of DMSO on a rabbit ear hypertrophic scar model: A controlled randomized experimental study.
Topics: Animals; Anti-Inflammatory Agents; Cicatrix, Hypertrophic; Collagen Type I; Collagen Type III; Dimethyl Sulfoxide; Disease Models, Animal; Ear; Free Radical Scavengers; Gene Expression; Injections, Intralesional; Interferon-gamma; Male; Neovascularization, Pathologic; Rabbits; Random Allocation; RNA, Messenger; Transforming Growth Factor beta1; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha | 2017 |
Comparing pegaptanib and triamcinolone efficacy in the rat choroidal neovascularization model.
Topics: Angiogenesis Inhibitors; Animals; Aptamers, Nucleotide; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Injections; Laser Coagulation; Male; Rats; Rats, Inbred BN; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |
Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Disease Models, Animal; Down-Regulation; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Glucocorticoids; Injections; Macular Edema; Membrane Proteins; Occludin; Ophthalmoscopy; Retinal Vein Occlusion; Swine; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2009 |
Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
Topics: Animals; Disease Models, Animal; Endophthalmitis; Eye; Eye Infections, Bacterial; Glucocorticoids; Injections; Male; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2009 |
Steroids do not prevent photoreceptor degeneration in the light-exposed T4R rhodopsin mutant dog retina irrespective of AP-1 inhibition.
Topics: Animals; Dark Adaptation; Dexamethasone; Disease Models, Animal; Dog Diseases; Dogs; Electrophoretic Mobility Shift Assay; Fluorescent Antibody Technique, Indirect; Glucocorticoids; Immunoblotting; Light; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Oligonucleotide Probes; Phosphorylation; Photoreceptor Cells, Vertebrate; Proto-Oncogene Proteins c-fos; Radiation Injuries, Experimental; Retinal Degeneration; Rhodopsin; Transcription Factor AP-1; Triamcinolone Acetonide | 2009 |
The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cyclophosphamide; Disease Models, Animal; Echinocandins; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Otitis Media; Pyrimidines; Rabbits; Triamcinolone Acetonide; Triazoles; Voriconazole | 2009 |
Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus.
Topics: Adenoviridae; Animals; Anterior Chamber; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Genetic Therapy; Genetic Vectors; Glucocorticoids; Intraocular Pressure; Matrix Metalloproteinase 1; Ocular Hypertension; Prednisolone; Sheep; Tonometry, Ocular; Triamcinolone Acetonide | 2010 |
The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Conjunctiva; Corneal Neovascularization; Disease Models, Animal; Drug Therapy, Combination; Glucocorticoids; Injections; Interleukin-6; Rabbits; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
Inhibition of choroidal neovascularization by intravitreal ketorolac.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Injections; Ketorolac; Macular Degeneration; Male; Rats; Rats, Inbred BN; Triamcinolone Acetonide; Vitreous Body | 2010 |
Improved assessment of laser-induced choroidal neovascularization.
Topics: Animals; Bruch Membrane; Choroidal Neovascularization; Cyclooxygenase Inhibitors; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Image Interpretation, Computer-Assisted; Intravitreal Injections; Ketorolac; Lasers, Gas; Male; Microscopy, Fluorescence; Rats; Rats, Inbred BN; Reproducibility of Results; Software; Specimen Handling; Time Factors; Triamcinolone Acetonide | 2010 |
Protective effects of triamcinolone acetonide upon the upregulation and phosphorylation of GAP 43 in an animal model of retinopathy of prematurity.
Topics: Animals; Blotting, Western; Disease Models, Animal; Female; GAP-43 Protein; Gene Expression Regulation; Glucocorticoids; Humans; Hyperoxia; Immunohistochemistry; Infant, Newborn; Oxygen; Phosphorylation; Pregnancy; Rats; Rats, Sprague-Dawley; Retinopathy of Prematurity; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triamcinolone Acetonide; Up-Regulation | 2010 |
Treatment with triamcinolone acetonide prevents decreased retinal levels of decorin in a rat model of oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; Blotting, Western; Cell Death; Decorin; Disease Models, Animal; Extracellular Matrix Proteins; Female; Glucocorticoids; Humans; Hyperoxia; Immunohistochemistry; In Situ Nick-End Labeling; Infant, Newborn; Oxygen; Pregnancy; Proteoglycans; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Retinopathy of Prematurity; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triamcinolone Acetonide | 2010 |
Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion.
Topics: Animals; Anterior Eye Segment; Ciliary Body; Cytoskeletal Proteins; Disease Models, Animal; Eye Proteins; Fluorescent Antibody Technique, Indirect; Glucocorticoids; Glycoproteins; Intraocular Pressure; Intravitreal Injections; Iris; Retinal Vein Occlusion; Swine; Trabecular Meshwork; Triamcinolone Acetonide | 2011 |
[Preliminary research on the relationship between inhibitory effect of triamcinolone acetonide on hypertrophic scar and oxygen free radicals in rabbits].
Topics: Animals; Cicatrix, Hypertrophic; Disease Models, Animal; Malondialdehyde; Rabbits; Random Allocation; Reactive Oxygen Species; Triamcinolone Acetonide | 2010 |
A comparison between the effects of three potential scar-reducing agents applied at a site of sciatic nerve repair.
Topics: Animals; Anti-Inflammatory Agents; Cicatrix; Disease Models, Animal; Interleukin-10; Mannosephosphates; Mice; Mice, Inbred C57BL; Nerve Regeneration; Peptide Fragments; Sciatic Neuropathy; Triamcinolone Acetonide | 2011 |
Effects of intravitreal triamcinolone acetonide on retinal gene expression in a rat model of central retinal vein occlusion.
Topics: Animals; Cytokines; Disease Models, Animal; Gene Expression Regulation; Glucocorticoids; Intercellular Signaling Peptides and Proteins; Intravitreal Injections; Ion Channels; Macular Edema; Rats; Rats, Inbred BN; Retina; Retinal Pigment Epithelium; Retinal Vein Occlusion; Reverse Transcriptase Polymerase Chain Reaction; Triamcinolone Acetonide | 2011 |
Feasibility study of corticosteroid treatment for esophageal ulcer after EMR in a canine model.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dogs; Esophageal Diseases; Esophageal Stenosis; Esophagoscopy; Esophagus; Feasibility Studies; Glucocorticoids; Immunohistochemistry; Injections; Mucous Membrane; Prednisolone; Triamcinolone Acetonide; Ulcer; Wound Healing | 2011 |
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.
Topics: Adrenal Cortex Hormones; Animals; Antimicrobial Cationic Peptides; Base Sequence; beta-Defensins; Betamethasone Valerate; Calcineurin Inhibitors; Case-Control Studies; Dermatitis, Atopic; Disease Models, Animal; DNA Primers; Fatty Acids, Essential; Gene Expression; Humans; Male; Mice; Mice, Hairless; RNA, Messenger; Skin Diseases, Bacterial; Tacrolimus; Triamcinolone Acetonide | 2011 |
Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Intravitreal Injections; Macular Degeneration; Male; Rabbits; Retina; Triamcinolone Acetonide; Vitreous Body | 2012 |
Enhanced transdermal delivery of 18β-glycyrrhetic acid via elastic vesicles: in vitro and in vivo evaluation.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dermatitis, Allergic Contact; Disease Models, Animal; Drug Stability; Drug Storage; Econazole; Glycyrrhetinic Acid; Liposomes; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Skin Absorption; Solubility; Time Factors; Triamcinolone Acetonide | 2012 |
Controlled release of triamcinolone acetonide from polyurethane implantable devices: application for inhibition of inflammatory-angiogenesis.
Topics: Animals; Anti-Inflammatory Agents; Biocompatible Materials; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Female; Inflammation; Materials Testing; Mice; Microscopy, Electron, Scanning; Neovascularization, Pathologic; Polyurethanes; Scattering, Small Angle; Spectroscopy, Fourier Transform Infrared; Triamcinolone Acetonide; X-Ray Diffraction | 2012 |
The impact of triamcinolone acetonide in early breast capsule formation in a rabbit model.
Topics: Animals; Anti-Inflammatory Agents; Breast Implants; Connective Tissue; Disease Models, Animal; Implant Capsular Contracture; Rabbits; Treatment Outcome; Triamcinolone Acetonide | 2012 |
The influence of triamcinolone on endostatin-like proteins in oxygen-induced retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Endostatins; Glucocorticoids; Humans; Infant, Newborn; Intravitreal Injections; Mice; Oxygen; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Triamcinolone Acetonide | 2012 |
Effect of glucocorticoid (triamcinolone acetonide) pretreatment in a murine penetrating keratoplasty and suture model.
Topics: Animals; Corneal Neovascularization; Disease Models, Animal; Glucocorticoids; Graft Survival; Intraocular Pressure; Keratitis; Keratoplasty, Penetrating; Lymphangiogenesis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Premedication; Suture Techniques; Triamcinolone Acetonide | 2012 |
A novel transdermal fomulation of 18β-glycyrrhetic acid with lysine for improving bioavailability and efficacy.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Biological Availability; Dermatitis, Allergic Contact; Disease Models, Animal; Dose-Response Relationship, Drug; Econazole; Gels; Glycyrrhetinic Acid; Inflammation; Liposomes; Lysine; Male; Mice; Mice, Inbred ICR; Skin Absorption; Swine; Triamcinolone Acetonide | 2012 |
Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.
Topics: Animals; Cornea; Corneal Neovascularization; Disease Models, Animal; Drug Synergism; Female; Glucocorticoids; Graft Survival; Keratoplasty, Penetrating; Lymphangiogenesis; Lymphatic Vessels; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Morpholinos; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2012 |
Triamcinolone acetonide prevents enhancement of hypoxia-induced neuronal and inducible nitric oxide synthases in the retinas of rats with oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; Blotting, Western; Disease Models, Animal; Female; Glucocorticoids; Hypoxia; Immunohistochemistry; Neurons; Nitric Oxide Synthase Type II; Oxygen; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Triamcinolone Acetonide | 2012 |
A new drug delivery system inhibits uveitis in an animal model after cataract surgery.
Topics: Animals; Anti-Inflammatory Agents; Biocompatible Materials; Cataract Extraction; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; Lactic Acid; Lens Implantation, Intraocular; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Triamcinolone Acetonide; Uveitis | 2013 |
Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes.
Topics: Animals; Cytoskeletal Proteins; Disease Models, Animal; Eye Proteins; Female; Glaucoma; Glucocorticoids; Glycoproteins; Hydrocortisone; Intraocular Pressure; Mice; Mice, Inbred C57BL; Microdialysis; Models, Biological; RNA, Messenger; Trabecular Meshwork; Triamcinolone Acetonide | 2013 |
Preliminary histopathological study of intra-articular injection of a novel highly cross-linked hyaluronic acid in a rabbit model of knee osteoarthritis.
Topics: Amides; Animals; Cartilage, Articular; Collagenases; Disease Models, Animal; Female; Hyaluronic Acid; Injections, Intra-Articular; Osteoarthritis, Knee; Rabbits; Ropivacaine; Triamcinolone Acetonide | 2013 |
A cotton rat model of human parainfluenza 3 laryngotracheitis: virus growth, pathology, and therapy.
Topics: Animals; Anti-Inflammatory Agents; Cilia; Disease Models, Animal; Dose-Response Relationship, Drug; Interferon-gamma; Laryngitis; Larynx; Parainfluenza Virus 3, Human; Rats; Respiratory Mucosa; Respirovirus Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sigmodontinae; Trachea; Tracheitis; Triamcinolone Acetonide; Virus Replication | 2002 |
Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants.
Topics: Animals; Anti-Inflammatory Agents; Choroidal Neovascularization; Disease Models, Animal; Drug Administration Schedule; Drug Implants; Glucocorticoids; Laser Coagulation; Male; Rats; Rats, Inbred BN; Triamcinolone Acetonide | 2003 |
Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Ear Diseases; Edema; Injections, Intravenous; Liposomes; Mice; Mice, Inbred Strains; Ointments; Skin; Skin Diseases; Time Factors; Triamcinolone Acetonide | 2003 |
Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model.
Topics: Acetamides; Animals; Antiviral Agents; Disease Models, Animal; Drug Therapy, Combination; Glucocorticoids; Guanidines; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Pyrans; Rats; Sialic Acids; Sigmodontinae; Triamcinolone Acetonide; Zanamivir | 2003 |
Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
Topics: Albuterol; Animals; Anti-Inflammatory Agents; Antiviral Agents; Bronchodilator Agents; Disease Models, Animal; Female; Glucocorticoids; Guanidines; Humans; Influenza A virus; Influenza, Human; Male; Neuraminidase; Pyrans; Respiration Disorders; Sialic Acids; Sigmodontinae; Triamcinolone Acetonide; Zanamivir | 2004 |
Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Disease Susceptibility; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Male; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Triamcinolone Acetonide; Vancomycin; Vitreous Body | 2005 |
Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.
Topics: Animals; Animals, Newborn; Cattle; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Fibroblast Growth Factor 2; Glucocorticoids; Humans; Infant, Newborn; Mice; Mice, Inbred C57BL; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Triamcinolone Acetonide | 2005 |
Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide.
Topics: Animals; Capillary Permeability; Choroidal Neovascularization; Chromatography, High Pressure Liquid; Connective Tissue; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Laser Coagulation; Male; Rats; Rats, Inbred BN; Triamcinolone Acetonide | 2005 |
Ischemia-reperfusion causes exudative detachment of the rabbit retina.
Topics: Animals; Calcium Channels; Cell Count; Disease Models, Animal; Exudates and Transudates; Female; Gliosis; Glucocorticoids; Male; Membrane Potentials; Microglia; Nerve Fibers; Photoreceptor Cells, Vertebrate; Pigment Epithelium of Eye; Potassium Channels; Rabbits; Receptors, Purinergic P2; Reperfusion Injury; Retinal Detachment; Retinal Vessels; Triamcinolone Acetonide | 2005 |
Apoptosis of skeletal muscle on steroid-induced myopathy in rats.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Disease Models, Animal; Female; Muscle, Skeletal; Muscular Diseases; Rats; Rats, Sprague-Dawley; Triamcinolone Acetonide | 2005 |
Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; Apoptosis; Capillaries; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Glucocorticoids; Humans; Infant, Newborn; Injections; Oxygen; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2006 |
Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.
Topics: Animals; Anti-Bacterial Agents; Cornea; Corneal Neovascularization; Cyclooxygenase Inhibitors; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Fibrinolytic Agents; Flurbiprofen; Glucocorticoids; Heparin, Low-Molecular-Weight; Male; Ophthalmic Solutions; Rats; Rats, Long-Evans; Treatment Outcome; Triamcinolone Acetonide | 2006 |
Steroid-induced ptosis: case studies and histopathologic analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Blepharoptosis; Disease Models, Animal; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Oculomotor Muscles; Rabbits; Retrospective Studies; Triamcinolone Acetonide; Uveitis | 2008 |
Influence of triamcinolone intravitreal injection on retinochoroidal healing processes.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Proliferation; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Glucocorticoids; In Situ Nick-End Labeling; Laser Coagulation; Mice; Mice, Inbred C57BL; Triamcinolone Acetonide; Wound Healing | 2007 |
Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model.
Topics: Animals; Animals, Newborn; Cell Count; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; Glucocorticoids; Humans; Infant, Newborn; Injections; Mice; Mice, Inbred C57BL; Oxygen; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Triamcinolone Acetonide; Vitreous Body | 2007 |
Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina.
Topics: Acridine Orange; Animals; Cell Communication; Disease Models, Animal; Endothelium, Vascular; Fluorescent Dyes; Gene Expression; Glucocorticoids; Injections; Intercellular Adhesion Molecule-1; Ischemia; Leukocytes; Macular Edema; Male; P-Selectin; Rats; Rats, Long-Evans; Retinal Diseases; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triamcinolone Acetonide | 2007 |
Inhibitory effects of topical thymoquinone on corneal neovascularization.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Triamcinolone Acetonide | 2007 |
Glucocorticoids for acute and persistent postoperative neuropathic pain: what is the evidence?
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Glucocorticoids; Humans; Pain, Postoperative; Rats; Spinal Nerves; Treatment Outcome; Triamcinolone Acetonide | 2007 |
Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuropathic pain.
Topics: Adrenal Cortex Hormones; Adrenergic Fibers; Animals; Anti-Inflammatory Agents; Behavior, Animal; Cytokines; Disease Models, Animal; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Spinal Nerves; Time Factors; Triamcinolone Acetonide | 2007 |
The effect of intracanal anti-inflammatory medicaments on external root resorption of replanted dog teeth after extended extra-oral dry time.
Topics: Animals; Anti-Inflammatory Agents; Demeclocycline; Dental Alloys; Desiccation; Disease Models, Animal; Dogs; Drug Combinations; Edetic Acid; Epoxy Resins; Glucocorticoids; Gutta-Percha; Nickel; Root Canal Filling Materials; Root Canal Irrigants; Root Canal Preparation; Root Resorption; Sodium Hypochlorite; Time Factors; Titanium; Tooth Avulsion; Tooth Replantation; Triamcinolone Acetonide; Wound Healing | 2008 |
Quantitative histological changes of repeated antigen-induced arthritis in the temporomandibular joints of rabbits treated with intra-articular corticosteroid.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Juvenile; Cell Count; Disease Models, Animal; Female; Joint Capsule; Plasma Cells; Rabbits; Statistics, Nonparametric; Synovial Membrane; Temporomandibular Joint; Temporomandibular Joint Disorders; Triamcinolone Acetonide | 2008 |
Effect of intravitreal triamcinolone acetonide on retinal apoptosis in experimental retinal neovascularization.
Topics: Animals; Animals, Newborn; Apoptosis; Disease Models, Animal; Glucocorticoids; Humans; Infant, Newborn; Mice; Mice, Inbred C57BL; Oxygen; Retina; Retinal Neovascularization; Retinopathy of Prematurity; Triamcinolone Acetonide; Vitreous Body | 2008 |
Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage.
Topics: Animals; Apoptosis; Disease Models, Animal; Female; Iron; Neuroprotective Agents; Photoreceptor Cells; Propoxycaine; Pupil; Rabbits; Retinal Hemorrhage; Triamcinolone Acetonide; Vitreous Body | 2008 |
Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Corneal Neovascularization; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Hydrogen-Ion Concentration; Male; Rats; Rats, Long-Evans; Triamcinolone Acetonide | 2008 |
Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation.
Topics: Animals; Cell Adhesion; Connective Tissue; Disease Models, Animal; Endothelium, Vascular; Fluorescent Antibody Technique, Indirect; Fluorophotometry; Glucocorticoids; Image Processing, Computer-Assisted; Intercellular Adhesion Molecule-1; Laser Coagulation; Leukocytes; Macular Edema; Male; Microcirculation; Rats; Rats, Inbred BN; Retina; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide | 2008 |
Congenital anomalies induced by triamcinolone acetonide in murine embryos.
Topics: Animals; Cleft Palate; Congenital Abnormalities; Disease Models, Animal; Embryo, Mammalian; Female; Glucocorticoids; Mice; Mice, Inbred ICR; Pregnancy; Receptors, Glucocorticoid; Triamcinolone Acetonide | 2008 |
Stimulation of proteoglycan synthesis by triamcinolone acetonide and insulin-like growth factor 1 in normal and arthritic murine articular cartilage.
Topics: Animals; Arthritis; Cartilage, Articular; Disease Models, Animal; Insulin-Like Growth Factor I; Male; Mice; Proteoglycans; Triamcinolone Acetonide | 1994 |
Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy.
Topics: Animals; Blood-Retinal Barrier; Cells, Cultured; Contrast Media; Disease Models, Animal; Eye Diseases; Female; Fibroblasts; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1994 |
The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization.
Topics: Animals; Disease Models, Animal; Fibroblasts; Fluorescein Angiography; Fundus Oculi; Hyaluronoglucosaminidase; Injections; Premedication; Rabbits; Retinal Neovascularization; Triamcinolone Acetonide; Vitreous Body | 1993 |
Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Carriers; Eye Diseases; Female; Injections; Liposomes; Macrophages; Male; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1993 |
Changes in phenotypically distinct phagocyte subpopulations during nonspecific modulation of contact sensitization.
Topics: Animals; Antibodies, Monoclonal; Croton Oil; Dermatitis, Contact; Disease Models, Animal; Female; Immunization; Immunoenzyme Techniques; Immunophenotyping; Macrophages; Mice; Mice, Inbred BALB C; Oxazolone; Phagocytes; Triamcinolone Acetonide | 1993 |
Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid.
Topics: Administration, Intranasal; Animals; Antibodies, Viral; Bronchiolitis; Combined Modality Therapy; Disease Models, Animal; Glucocorticoids; Immunoglobulin G; Lung; Parainfluenza Virus 3, Human; Paramyxoviridae Infections; Pneumonia, Viral; Rats; Sigmodontinae; Time Factors; Triamcinolone Acetonide; Virus Replication | 1996 |
Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.
Topics: Animals; Disease Models, Animal; Glucocorticoids; Injections; Male; Optic Disk; Retinal Neovascularization; Retinal Vein Occlusion; Swine; Triamcinolone Acetonide; Vitreous Body | 1996 |
Insulin-like growth factor 1 and corticosteroid modulation of chondrocyte metabolic and mitogenic activities in interleukin 1-conditioned equine cartilage.
Topics: Adrenal Cortex Hormones; Analysis of Variance; Animals; Anti-Inflammatory Agents; Cartilage; Cell Division; Cells, Cultured; Collagen; Disease Models, Animal; DNA; Drug Interactions; Glycosaminoglycans; Homeostasis; Horse Diseases; Horses; Insulin-Like Growth Factor I; Interleukin-1; Male; Osteoarthritis; Proteoglycans; Sulfates; Sulfur Radioisotopes; Thymidine; Triamcinolone Acetonide; Tritium | 1997 |
Acute and chronic animal models for excessive dermal scarring: quantitative studies.
Topics: Animals; Cicatrix; Dermatologic Surgical Procedures; Disease Models, Animal; Female; Injections, Intralesional; Rabbits; Sodium Chloride; Triamcinolone Acetonide | 1997 |
Contact lens-induced infection--a new model of Candida albicans keratitis.
Topics: Animals; Candida albicans; Candidiasis; Conjunctiva; Contact Lenses; Cornea; Disease Models, Animal; Eye Infections, Fungal; Female; Glucocorticoids; Keratitis; Male; Rabbits; Triamcinolone Acetonide | 1999 |
Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.
Topics: Animals; Anti-Inflammatory Agents; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Injections; Laser Coagulation; Male; Rats; Rats, Inbred BN; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body | 2001 |
Effects of antiinflammatory agents on the acute response of immune synovitis in rabbits.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Colchicine; Disease Models, Animal; Dose-Response Relationship, Immunologic; Glucuronidase; Indomethacin; Lysosomes; Methods; Niflumic Acid; Phenylbutazone; Prednisolone; Rabbits; Serum Albumin, Bovine; Synovitis; Triamcinolone Acetonide | 1977 |
Intra-articular corticosteroid reduces joint stiffness after an experimental periarticular fracture.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Edema; Female; Fractures, Bone; Humans; Immobilization; Injections, Intra-Articular; Joint Diseases; Rabbits; Range of Motion, Articular; Triamcinolone Acetonide | 1992 |
The lack of an effect of intraocular steroids on irradiated fibroblasts in experimental proliferative vitreoretinopathy.
Topics: Animals; Cesium Radioisotopes; Disease Models, Animal; Eye Diseases; Female; Fibroblasts; Injections; Male; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1992 |
The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Eye Diseases; Female; Fibroblasts; Fundus Oculi; Male; Rabbits; Random Allocation; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1992 |
Influence of corticosteroid on experimentally induced keratomycosis.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Keratitis; Rabbits; Triamcinolone Acetonide | 1991 |
Mouse major histocompatibility complex and lung development: haplotype variation, H-2 immunolocalization, and progressive maturation.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Embryonic and Fetal Development; Female; Fluorescent Antibody Technique; H-2 Antigens; Haplotypes; Lung; Major Histocompatibility Complex; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Respiratory Distress Syndrome, Newborn; Triamcinolone Acetonide | 1991 |
In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model.
Topics: Administration, Oral; Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Injections, Intra-Articular; Osteoarthritis; Propionates; Triamcinolone Acetonide | 1991 |
Triamcinolone acetonide-induced meningocele and meningoencephalocele in rhesus monkeys.
Topics: Animals; Disease Models, Animal; Encephalocele; Humans; Injections, Intramuscular; Macaca mulatta; Meningocele; Triamcinolone Acetonide | 1990 |
The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Disease Models, Animal; Eye Diseases; Neovascularization, Pathologic; Rabbits; Retinal Detachment; Retinal Diseases; Retinal Perforations; Time Factors; Triamcinolone Acetonide; Vitreous Body | 1985 |
An attempt to develop a model to study the effects of intrathecal steroids.
Topics: Animals; Arachnoiditis; Cefoxitin; Desoxycorticosterone; Disease Models, Animal; Drug Interactions; Injections, Spinal; Male; Meningitis; Meningitis, Aseptic; Methylprednisolone; Methylprednisolone Hemisuccinate; Rats; Rats, Inbred Strains; Spinal Cord Diseases; Triamcinolone Acetonide | 1986 |
Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Eye Diseases; Fibroblasts; Rabbits; Retinal Detachment; Retinal Diseases; Transplantation, Homologous; Triamcinolone Acetonide; Vitreous Body | 1987 |
Tetrahydrotriamcinolone and triamcinolone. II. Effect on xenograft reaction in rabbits.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Corneal Transplantation; Dexamethasone; Disease Models, Animal; Glaucoma; Glucocorticoids; Graft Rejection; Ophthalmic Solutions; Rabbits; Swine; Transplantation, Heterologous; Triamcinolone Acetonide | 1972 |
Lesions of dermatophytosis in quinea pigs treated with triamcinolone acetonide: an animal model.
Topics: Animals; Dermatomycoses; Disease Models, Animal; Guinea Pigs; Hair; Injections, Subcutaneous; Male; Microsporum; Rodent Diseases; Skin; Tinea; Triamcinolone Acetonide; Trichophyton | 1973 |
Quantitative effect of topically applied anti-inflammatory agents on external ocular inflammation in rats.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Croton Oil; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Eye Diseases; Female; Fluocinolone Acetonide; Hydrocortisone; Inflammation; Irritants; Rats; Time Factors; Triamcinolone; Triamcinolone Acetonide | 1973 |
[Comparative evaluation of antihyperplastic effects of topical corticosteroids on animal epidermis (author's transl)].
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Betamethasone; Cell Division; Disease Models, Animal; Drug Combinations; Ethanol; Flumethasone; Guinea Pigs; Hydrocortisone; Hyperplasia; Male; Palmitic Acids; Skin Diseases; Skin Tests; Steroids, Fluorinated; Triamcinolone Acetonide | 1973 |